Emil Skamene
Corporate Officer/Principal chez Neurochem (International) Ltd.
Profil
Emil Skamene is the founder of Emerillon Therapeutics, Inc. which was founded in 2003.
He is currently a Member-Management Board at Neurochem (International) Ltd.
Dr. Skamene has formerly worked as a Director at BELLUS Health, Inc. and as a Scientific Director-Research Institute at McGill University Health Center.
Postes actifs de Emil Skamene
| Sociétés | Poste | Début |
|---|---|---|
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Corporate Officer/Principal | - |
Anciens postes connus de Emil Skamene
| Sociétés | Poste | Fin |
|---|---|---|
McGill University Health Center
 McGill University Health Center Hospital/Nursing ManagementHealth Services McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada. | Directeur Technique/Scientifique/R&D | - |
Emerillon Therapeutics, Inc.
 Emerillon Therapeutics, Inc. BiotechnologyHealth Technology Emerillon Therapeutics, Inc. used to develop genomics-based drugs for human complex diseases through its unique RCS mouse platform technology, its access to human patient samples, and its expertise in high throughput mutation screening and ion channel genomics. It also offers contract services, such as mutation detection using dHPLC, mouse genotyping, and speed congenesis. The company was founded in January 2003 and is headquartered was Montréal, Canada. | Fondateur | - |
| BELLUS HEALTH | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
McGill University Health Center
McGill University Health Center Hospital/Nursing ManagementHealth Services McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada. | Health Services |
Neurochem (International) Ltd.
Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Commercial Services |
Emerillon Therapeutics, Inc.
Emerillon Therapeutics, Inc. BiotechnologyHealth Technology Emerillon Therapeutics, Inc. used to develop genomics-based drugs for human complex diseases through its unique RCS mouse platform technology, its access to human patient samples, and its expertise in high throughput mutation screening and ion channel genomics. It also offers contract services, such as mutation detection using dHPLC, mouse genotyping, and speed congenesis. The company was founded in January 2003 and is headquartered was Montréal, Canada. | Health Technology |
